NTT Biopharma 奈力生醫
Manufacturing · Taiwan · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Ntu Incubation Center Building B No. 18 ...Website
www.nttbiopharma.comRevenue
<$5 MillionIndustry
About NTT Biopharma 奈力生醫
Is NTT Biopharma 奈力生醫 your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once NTT Biopharma 奈力生醫 has new funding data
NTT Biopharma 奈力生醫, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when NTT Biopharma 奈力生醫 launches new products
Congratulate Masked Content for being promoted to Masked Content at NTT Biopharma 奈力生醫
Earning: See what the market has to say on NTT Biopharma 奈力生醫 recently announced quarterly report
Click to see if NTT Biopharma 奈力生醫 had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if NTT Biopharma 奈力生醫 has recently received funding, and reach out quickly before it becomes old news!
Check out if NTT Biopharma 奈力生醫 is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined NTT Biopharma 奈力生醫 as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
NTT Biopharma 奈力生醫 is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NTT Biopharma 奈力生醫 is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NTT Biopharma 奈力生醫.
NTT Biopharma 奈力生醫 Tech Stack
A closer look at the technologies used by NTT Biopharma 奈力生醫
Top Manufacturing Companies
Frequently Asked Questions Regarding NTT Biopharma 奈力生醫
NTT Biopharma Inc. is a pioneering biotechnology company specializing in the use of mesoporous silica nanoparticles (MSNs) for targeted drug delivery. The company aims to address unmet medical needs in brain diseases, ocular and retinal diseases, oncology, and gene therapy by developing a new generation of effective nanomedicines. Their proprietary... Read More